» Articles » PMID: 24516598

Serum Adhesion Molecule Levels As Prognostic Markers in Patients with Early Systemic Sclerosis: a Multicentre, Prospective, Observational Study

Abstract

Objective: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease.

Methods: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstitial lung disease were registered in a multicentre, observational study. Concentrations of intercellular adhesion molecule (ICAM) -1, E-selectin, L-selectin, and P-selectin in serum samples from all patients were measured by enzyme-linked immunosorbent asssay (ELISA). In 39 patients, adhesion molecule levels were measured each year for four years. The ability of baseline adhesion molecule levels to predict subsequent progression and severity in clinical and laboratory features were evaluated statistically.

Results: At their first visit, serum levels of ICAM-1, E-selection, P-selectin were significantly elevated and serum L-selectin levels were significantly reduced in patients with SSc compared with healthy controls. Overall, serum ICAM-1 levels at each time point were significantly inversely associated with the %vital capacity (VC) of the same time and subsequent years by univariate analysis. The initial serum ICAM-1 levels were significantly inversely associated with the %VC at the fourth year by multiple regression analysis. The initial serum P-selectin levels were significantly associated with the health assessment questionnaire disability index (HAQ-DI) at the fourth year by multiple regression analysis. Initial adhesion molecule levels were not significantly associated with other clinical features including skin thickness score. Baseline adhesion molecule levels were not significantly associated with subsequent rate of change of clinical parameters.

Conclusion: In patients with SSc, serum levels of ICAM-1 and P-selectin may serve as prognostic indicators of respiratory dysfunction and physical disability, respectively. Further longitudinal studies of larger populations are needed to confirm these findings.

Citing Articles

PSGL-1, ADAM8, and selectins as potential biomarkers in the diagnostic process of systemic lupus erythematosus and systemic sclerosis: an observational study.

San Antonio E, Silvan J, Sevilla-Montero J, Gonzalez-Sanchez E, Munoz-Callejas A, Sanchez-Abad I Front Immunol. 2024; 15:1403104.

PMID: 39100683 PMC: 11297358. DOI: 10.3389/fimmu.2024.1403104.


Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis.

Parker M, Jee A, Hansen D, Proudman S, Youssef P, Kenna T Rheumatology (Oxford). 2024; 63(11):2981-2988.

PMID: 38366632 PMC: 11534140. DOI: 10.1093/rheumatology/keae110.


Immune-related signature of periodontitis and Alzheimer's disease linkage.

Jin J, Guang M, Li S, Liu Y, Zhang L, Zhang B Front Genet. 2023; 14:1230245.

PMID: 37849501 PMC: 10577303. DOI: 10.3389/fgene.2023.1230245.


E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases.

Pulito-Cueto V, Remuzgo-Martinez S, Genre F, Atienza-Mateo B, Mora-Cuesta V, Iturbe-Fernandez D Int J Mol Sci. 2023; 24(15).

PMID: 37569893 PMC: 10420063. DOI: 10.3390/ijms241512518.


Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.

Pugashetti J, Khanna D, Kazerooni E, Oldham J Immunol Allergy Clin North Am. 2023; 43(2):411-433.

PMID: 37055096 PMC: 10584384. DOI: 10.1016/j.iac.2023.01.012.


References
1.
Steen V, Powell D, Medsger Jr T . Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988; 31(2):196-203. DOI: 10.1002/art.1780310207. View

2.
Varki A . Selectin ligands. Proc Natl Acad Sci U S A. 1994; 91(16):7390-7. PMC: 44407. DOI: 10.1073/pnas.91.16.7390. View

3.
Pigott R, Dillon L, Hemingway I, Gearing A . Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992; 187(2):584-9. DOI: 10.1016/0006-291x(92)91234-h. View

4.
Steen V . Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005; 35(1):35-42. DOI: 10.1016/j.semarthrit.2005.03.005. View

5.
Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, Kitaba S . Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One. 2012; 7(7):e41994. PMC: 3404023. DOI: 10.1371/journal.pone.0041994. View